Distribution of surface-protein variants of hyperinvasive meningococci in China

Journal of Infection

Volumn 58, Issue 5, 2009, Pages 358-367

  Yang, Li ^a   Zhang, Xiaobing ^a   Peng, Junping ^a   Zhu, Yafang ^a   Dong, Jie ^a   Xu, Jianguo ^b   Jin, Qi ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b National Institute for Communicable Disease Control and Prevention   (China)

Author keywords

FetA typing; Hyperinvasive lineages; Neisseria meningitidis; Outer membrane protein (OMP); PorB typing

Indexed keywords

FETA PROTEIN; OUTER MEMBRANE PROTEIN; PORB PROTEIN; UNCLASSIFIED DRUG;

ANTIGENIC VARIATION; ARTICLE; BACTERIAL STRAIN; CHINA; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; MENINGOCOCCOSIS; MOLECULAR EPIDEMIOLOGY; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PUBLIC HEALTH; STRAIN DIFFERENCE;

ANTIGENIC VARIATION; BACTERIAL OUTER MEMBRANE PROTEINS; CHINA; DNA, BACTERIAL; HUMANS; MEMBRANE PROTEINS; MENINGITIS, MENINGOCOCCAL; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; PORINS; SEQUENCE ANALYSIS, DNA;

EID: 67349187462     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.02.020     Document Type: Article

References (50)

1. Achtman M. Epidemic spread and antigenic variability of Neisseria meningitidis. Trends Microbiol 3 5 (1995) 186-192
2. Peltola H. Meningococcal disease: still with us. Rev Infect Dis 5 1 (1983) 71-91
3. Jolley K.A., Brehony C., and Maiden M.C. Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev 31 1 (2007) 89-96
4. Maiden M.C., and Feavers I.M. Meningococcal typing. J Med Microbiol 40 3 (1994) 157-158
5. Sacchi C.T., Lemos A.P., Whitney A.M., Solari C.A., Brandt M.E., Melles C.E., et al. Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system. Clin Diagn Lab Immunol 5 3 (1998) 348-354
6. Sorhouet Pereira C., Regueira M., and Mollerach M. PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine. J Med Microbiol 57 Pt 3 (2008) 338-342
7. Maiden M.C., and Frosch M. Molecular techniques for the investigation of meningococcal disease epidemiology. Mol Biotechnol 18 2 (2001) 119-134
8. Cartwright K., Morris R., Rumke H., Fox A., Borrow R., Begg N., et al. Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins. Vaccine 17 20-21 (1999) 2612-2619
9. O'Hallahan J., Lennon D., and Oster P. The strategy to control New Zealand's epidemic of group B meningococcal disease. Pediatr Infect Dis J 23 Suppl. 12 (2004) S293-S298
10. Feavers I.M., Fox A.J., Gray S., Jones D.M., and Maiden M.C. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design. Clin Diagn Lab Immunol 3 4 (1996) 444-450
11. Urwin R., Russell J.E., Thompson E.A., Holmes E.C., Feavers I.M., and Maiden M.C. Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun 72 10 (2004) 5955-5962
12. Russell J.E., Jolley K.A., Feavers I.M., Maiden M.C., and Suker J. PorA variable regions of Neisseria meningitidis. Emerg Infect Dis 10 4 (2004) 674-678
13. Sacchi C.T., Lemos A.P., Popovic T., Morais J.C., Whitney A.M., Melles C.E., et al. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997-1998: overview and implications for vaccine development. J Clin Microbiol 39 8 (2001) 2897-2903
14. Wright J.C., Williams J.N., Christodoulides M., and Heckels J.E. Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis. Infect Immun 70 8 (2002) 4028-4034
15. Thompson E.A., Feavers I.M., and Maiden M.C. Antigenic diversity of meningococcal enterobactin receptor FetA, a vaccine component. Microbiology 149 Pt 7 (2003) 1849-1858
16. Black J.R., Dyer D.W., Thompson M.K., and Sparling P.F. Human immune response to iron-repressible outer membrane proteins of Neisseria meningitidis. Infect Immun 54 3 (1986) 710-713
17. Jodar L., Feavers I.M., Salisbury D., and Granoff D.M. Development of vaccines against meningococcal disease. Lancet 359 9316 (2002) 1499-1508
18. Wedege E., Hoiby E.A., Rosenqvist E., and Bjune G. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccines and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial. Infect Immun 66 7 (1998) 3223-3231
19. van der Ley P., van der Biezen J., Sutmuller R., Hoogerhout P., and Poolman J.T. Sequence variability of FrpB, a major iron-regulated outer-membrane protein in the pathogenic neisseriae. Microbiology 142 Pt 11 (1996) 3269-3274
20. van der Ley P., Heckels J.E., Virji M., Hoogerhout P., and Poolman J.T. Topology of outer membrane porins in pathogenic Neisseria spp. Infect Immun 59 9 (1991) 2963-2971
21. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95 6 (1998) 3140-3145
22. Yazdankhah S.P., Kriz P., Tzanakaki G., Kremastinou J., Kalmusova J., Musilek M., et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 42 11 (2004) 5146-5153
23. Shao Z., Li W., Ren J., Liang X., Xu L., Diao B., et al. Identification of a new Neisseria meningitidis serogroup C clone from Anhui province, China. Lancet 367 9508 (2006) 419-423
24. Zhu P., Hu X., and Xu L. Typing Neisseria meningitidis by analysis of restriction fragment length polymorphisms in the gene encoding the class 1 outer membrane protein: application to assessment of epidemics throughout the last 4 decades in China. J Clin Microbiol 33 2 (1995) 458-462
25. Zhang X., Shao Z., Zhu Y., Xu L., Xu X., Mayer L.W., et al. Genetic characteristics of serogroup A meningococci circulating in China, 1956-2005. Clin Microbiol Infect (2008)
26. Yang L., Shao Z., Zhang X., Xu L., Peng J., Xu X., et al. Genotypic characterization of Neisseria meningitidis serogroup B strains circulating in China. J Infect 56 3 (2008) 211-218
27. Peng J., Yang L., Yang F., Yang J., Yan Y., Nie H., et al. Characterization of ST-4821 complex, a unique Neisseria meningitidis clone. Genomics 91 1 (2008) 78-87
28. Zhang X., Shao Z., Yang E., Xu L., Xu X., Li M., et al. Molecular characterization of serogroup C Neisseria meningitidis isolated in China. J Med Microbiol 56 Pt 9 (2007) 1224-1229
29. Zapata G.A., Vann W.F., Rubinstein Y., and Frasch C.E. Identification of variable region differences in Neisseria meningitidis class 3 protein sequences among five group B serotypes. Mol Microbiol 6 23 (1992) 3493-3499
30. Caugant D.A., Mocca L.F., Frasch C.E., Froholm L.O., Zollinger W.D., and Selander R.K. Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol 169 6 (1987) 2781-2792
31. Suker J., Feavers I.M., Achtman M., Morelli G., Wang J.F., and Maiden M.C. The porA gene in serogroup A meningococci: evolutionary stability and mechanism of genetic variation. Mol Microbiol 12 2 (1994) 253-265
32. Wang J.F., Caugant D.A., Morelli G., Koumare B., and Achtman M. Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis 167 6 (1993) 1320-1329
33. Russell J.E., Urwin R., Gray S.J., Fox A.J., Feavers I.M., and Maiden M.C. Molecular epidemiology of meningococcal disease in England and Wales 1975-1995, before the introduction of serogroup C conjugate vaccines. Microbiology 154 Pt 4 (2008) 1170-1177
34. Feavers I.M., Heath A.B., Bygraves J.A., and Maiden M.C. Role of horizontal genetic exchange in the antigenic variation of the class 1 outer membrane protein of Neisseria meningitidis. Mol Microbiol 6 4 (1992) 489-495
35. Tondella M.L., Popovic T., Rosenstein N.E., Lake D.B., Carlone G.M., Mayer L.W., et al. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. J Clin Microbiol 38 9 (2000) 3323-3328
36. Achtman M. Microevolution and epidemic spread of serogroup A Neisseria meningitidis - a review. Gene 192 1 (1997) 135-140
37. Moore P.S., Reeves M.W., Schwartz B., Gellin B.G., and Broome C.V. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet 2 8657 (1989) 260-263
38. Wang J.F., Caugant D.A., Li X., Hu X.J., Poolman J.T., Crowe B.A., et al. Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China. Infect Immun 60 12 (1992) 5267-5282
39. Tzeng Y.L., and Stephens D.S. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect 2 6 (2000) 687-700
40. Smith N.H., Maynard Smith J., and Spratt B.G. Sequence evolution of the porB gene of Neisseria gonorrhoeae and Neisseria meningitidis: evidence of positive Darwinian selection. Mol Biol Evol 12 3 (1995) 363-370
41. Nicolas P., Decousset L., Riglet V., Castelli P., Stor R., and Blanchet G. Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerg Infect Dis 7 5 (2001) 849-854
42. Nicolas P., Norheim G., Garnotel E., Djibo S., and Caugant D.A. Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. J Clin Microbiol 43 10 (2005) 5129-5135
43. Chiou C.S., Liao J.C., Liao T.L., Li C.C., Chou C.Y., Chang H.L., et al. Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan. BMC Infect Dis 6 (2006) 25
44. Sacchi C.T., Whitney A.M., Popovic T., Beall D.S., Reeves M.W., Plikaytis B.D., et al. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis 182 4 (2000) 1169-1176
45. Gupta S., and Maiden M.C. Exploring the evolution of diversity in pathogen populations. Trends Microbiol 9 4 (2001) 181-185
46. Diggle M.A., and Clarke S.C. Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines. J Clin Microbiol 43 9 (2005) 4649-4653
47. Swartley J.S., Marfin A.A., Edupuganti S., Liu L.J., Cieslaki P., Perkins B., et al. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci U S A 94 1 (1997) 271-276
48. Norheim G., Aase A., Caugant D.A., Høiby E.A., Fritzsønn E., Tangen T., et al. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis. Vaccine 23 29 (2005) 3762-3774
49. Pettersson A., Kuipers B., Pelzer M., Verhagen E., Tiesjema R.H., Tommassen J., et al. Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific. Infect Immun 58 9 (1990) 3036-3041
50. Saukkonen K., Leinonen M., Abdillahi H., and Poolman J.T. Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine 7 4 (1989) 325-328